Body Mass Index and the Risk of Hypertension-Diabetes Comorbidity in Elderly Population: A Prospective Cohort in China
Global Heart · 2025
DOI: 10.5334/gh.1487 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Global Heart, 2025. Verfasst von Haimeng Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nanchang University, Jiangxi, 330031, China. Hauptthemen laut MEDLINE: Body Mass Index, Diabetes Mellitus, Hypertension. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Body mass index (BMI) is closely linked to hypertension and diabetes mellitus (DM). However, the association between BMI and hypertension-diabetes comorbidity in elderly population of China remains uncertain.
Methods
This cohort study was conducted based on a prospective database of Chinese Longitudinal Healthy Longevity Survey (CLHLS). The primary outcome was hypertension-diabetes comorbidity. The secondary outcomes included hypertension and DM. BMI was categorized into four groups according to Chinese guidelines: underweight (BMI < 18.5 kg/m2), normal weight (BMI 18.5–23.9 kg/m2), overweight (BMI 24.0–27.9 kg/m2), and obesity (BMI ≥ 28.0 kg/m2).
Results
The final analysis included 5,342 individuals for hypertension, 6,335 for DM, and 6,414 for hypertension-diabetes comorbidity (all individuals aged 65 years and above). Cox regression analysis of the hypertension-diabetes comorbidity revealed the adjusted hazard ratio (HR) for the underweight group was 0.747 (95% confidence interval [CI], 0.651–0.857), for the overweight group was 1.517 (95% CI, 1.309–1.758), and for the obesity group was 1.620 (95% CI, 1.237–2.121) comparing with normal weight group (reference). When considering BMI as a continuous variable, the adjusted HR was 1.043 (95% CI, 1.029–1.059). Employing a multi-model adjusting strategy based on the directed acyclic graph, the HR for individuals with BMI ≥ 24.0 (versus BMI < 24.0) was 1.486 (95% CI, 1.301–1.698). Restricted cubic splines indicate a positive linear trend between BMI (range in BMI ≥ 24) and the risk of hypertension-diabetes comorbidity. The relationship between BMI and secondary outcomes exhibited results similar to those of the primary outcome. Additionally, compared to the Han ethnic, other ethnic had a significantly lower risk of the primary outcome, with an adjusted HR of 0.334 (95% CI, 0.235–0.475). Similar findings were observed for the secondary outcomes.
Conclusions
Increased BMI is significantly associated with a higher risk of hypertension-diabetes comorbidity, hypertension, and DM in elderly population of China. Additionally, Han participants (versus non-Han) have a notably greater risk of developing hypertension-diabetes comorbidity, hypertension, and DM. Greater attention should be paid to obesity in elderly Han Chinese individuals, given its significant associated disease burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nanchang University, Jiangxi, 330031, China.
- Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan 430030, China.
Zitieren
APA
Zhang, H., Li, G., Li, F., & Jiang, J. (2025). Body Mass Index and the Risk of Hypertension-Diabetes Comorbidity in Elderly Population: A Prospective Cohort in China. Global Heart. https://doi.org/10.5334/gh.1487
Vancouver
Zhang H, Li G, Li F, Jiang J. Body Mass Index and the Risk of Hypertension-Diabetes Comorbidity in Elderly Population: A Prospective Cohort in China. Global Heart. 2025. doi:10.5334/gh.1487
BibTeX
@article{Zhang2025,
author = {Zhang, Haimeng and Li, Guangling and Li, Fan and Jiang, Jiangang},
title = {Body Mass Index and the Risk of Hypertension-Diabetes Comorbidity in Elderly Population: A Prospective Cohort in China},
journal = {Global Heart},
year = {2025},
doi = {10.5334/gh.1487}
}
EUVIMED